Salardi S, Tonioli S, Tassoni P, Tellarini M, Mazzanti L, Cacciari E
Arch Dis Child. 1987 Jan;62(1):57-62. doi: 10.1136/adc.62.1.57.
Growth of 79 children with diabetes was analysed at diagnosis and again after one to 10.7 years of treatment with insulin. Both sexes were tall at onset, whereas at the last observation boys alone showed significant growth retardation. Height standard deviation score (SDS), however, showed no significant fall either in 32 subjects reassessed after five years of disease or in 18 subjects examined at full stature. Skeletal maturity was not significantly impaired after treatment. Pubertal growth spurt was reduced, especially in girls and in subjects with onset of disease at or around puberty. We found no significant correlation between height and height velocity SDS and glycosylated haemoglobin values or secretion of growth hormone during the arginine test. Somatomedin C values were correlated with height velocity SDS in prepubertal boys. The results of this study suggest that there are interferences in the growth of children with diabetes but that they do not seem to have a significant influence on adult height.
对79例糖尿病患儿在诊断时以及接受胰岛素治疗1至10.7年后再次进行了生长情况分析。两性在发病时身高均较高,而在最后一次观察时,仅男孩出现了显著的生长迟缓。然而,身高标准差评分(SDS)在患病五年后重新评估的32名受试者中或在达到成年身高时检查的18名受试者中均未出现显著下降。治疗后骨骼成熟度未受到显著损害。青春期生长突增减少,尤其是在女孩以及在青春期或青春期前后发病的受试者中。我们发现身高和身高增长速度SDS与糖化血红蛋白值或精氨酸试验期间生长激素分泌之间无显著相关性。在青春期前男孩中,生长介素C值与身高增长速度SDS相关。本研究结果表明,糖尿病患儿的生长存在干扰因素,但这些因素似乎对成年身高没有显著影响。